| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
18,740,000 |
| Market
Cap: |
56.22(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.62 - $4.4 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 5.8 |
| Insider 3/6 Months : 6.4 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile DiaMedica Therapeutics is a biopharmaceutical company engaged in developing novel therapeutic products to improve the lives of people with Type 1 diabetes, Type 2 diabetes and other significant diseases with unmet medical needs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
20,000 |
1,667,889 |
5,405,460 |
| Total Buy Value |
$0 |
$49,200 |
$5,742,445 |
$10,565,177 |
| Total People Bought |
0 |
1 |
7 |
8 |
| Total Buy Transactions |
0 |
1 |
8 |
21 |
| Total Shares Sold |
0 |
0 |
0 |
2,855,847 |
| Total Sell Value |
$0 |
$0 |
$0 |
$3,526,971 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Parsons James T. |
Director |
– • – |
2020-06-01 |
4 |
A |
$4.59 |
$37,188 |
D/D |
8,102 |
14,202 |
|
- |
|
| Kellen Scott |
CFO and Secretary |
• – – |
2019-08-19 |
4 |
B |
$2.43 |
$7,290 |
D/D |
3,000 |
10,290 |
2.74 |
- |
|
| Pilnik Richard D. |
Director |
– • – |
2019-08-16 |
4 |
B |
$2.56 |
$20,039 |
D/D |
7,840 |
50,678 |
2.39 |
- |
|
| Pauls Dietrich John |
President and CEO |
• • – |
2019-08-16 |
4 |
B |
$2.68 |
$2,677 |
D/D |
1,000 |
30,804 |
2.73 |
- |
|
| Alcorn Harry W Jr |
Chief Medical Officer |
• – – |
2019-08-16 |
4 |
B |
$2.67 |
$19,365 |
D/D |
7,260 |
8,260 |
2.74 |
- |
|
| Pilnik Richard D. |
Director |
– • – |
2019-05-31 |
4 |
B |
$2.80 |
$53,200 |
D/D |
19,000 |
42,838 |
2.39 |
- |
|
| Kellen Scott |
CFO and Secretary |
• – – |
2019-05-24 |
4 |
B |
$2.94 |
$11,770 |
D/D |
4,000 |
7,290 |
2.74 |
- |
|
| Alcorn Harry W Jr |
Chief Medical Officer |
• – – |
2019-03-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
1,000 |
|
- |
|
| Alcorn Harry W Jr |
Chief Medical Officer |
• – – |
2019-03-27 |
4 |
B |
$4.46 |
$668 |
D/D |
150 |
1,150 |
2.66 |
- |
|
| Pauls Dietrich John |
President and CEO |
• • – |
2018-12-11 |
4 |
B |
$4.00 |
$20,000 |
D/D |
5,000 |
29,804 |
2.81 |
- |
|
| Pilnik Richard D. |
Director |
– • – |
2018-12-11 |
4 |
B |
$4.00 |
$25,000 |
D/D |
6,250 |
23,838 |
2.39 |
- |
|
| Parsons James T. |
Director |
– • – |
2018-12-11 |
4 |
B |
$4.00 |
$9,000 |
D/D |
2,250 |
6,100 |
2.39 |
- |
|
| Xiao Zhenyu |
Director |
– • • |
2018-12-11 |
4 |
B |
$4.00 |
$13,000 |
D/D |
3,250 |
7,100 |
3.92 |
- |
|
| Giuffre Randall Michael |
Director |
– • – |
2018-12-11 |
4 |
B |
$4.00 |
$45,000 |
D/D |
11,250 |
85,804 |
2.39 |
- |
|
| Kellen Scott |
CFO and Secretary |
• – – |
2018-12-11 |
4 |
B |
$4.00 |
$5,000 |
D/D |
1,250 |
3,290 |
2.74 |
- |
|
| Alcorn Harry W Jr |
Chief Medical Officer |
• – – |
2018-12-11 |
4 |
B |
$4.00 |
$4,000 |
D/D |
1,000 |
1,000 |
2.66 |
- |
|
| Verdoorn Todd A. |
Chief Scientific Officer |
• – – |
2018-12-11 |
4 |
B |
$4.00 |
$4,000 |
D/D |
1,000 |
2,000 |
2.66 |
- |
|
67 Records found
|
|
Page 3 of 3 |
|
|
0.37 (14.07%) 
